Fairchem Organics Limited (FAIRCHEMOR) fair value: what the stock is really worth
As of Nov 12, 2026: fair value (intrinsic value) of Fairchem Organics Limited stock ₹150, price ₹685, that is 78.2% below the price, quality 55 out of 100. Rating: strongly overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹433.00 – ₹2,237 · fair‑value band ₹112.16 – ₹186.94 · the ₹684.95 price screens above the ₹149.56 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Follow Fairchem Organics in your weekly email
Every Wednesday you see whether Fairchem Organics is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals.
Show moreShow less
It provides nutraceuticals comprising natural and mixed tocopherol and sterol concentrates; and oleo chemicals, such as dimer, isostearic, linoleic acid, stearic, palmitic, and distilled fatty acid products, as well as monobasic acid.
The company operates in India, East Asia, the Middle East, North America, South America, Europe, and Southeast Asia.
It serves companies/firms that produces epoxy hardeners, paints, printing inks, natural vitamin E, pet food, soaps, pharma; makes and trades in lubricants and cosmetics; and oil drilling operations. The company was incorporated in 2019 and is based in Ahmedabad, India.
Fairchem Organics Limited operates as a subsidiary of Fih Mauritius Investments Limited.
Stock analysis
Fairchem Organics Limited (FAIRCHEMOR) currently trades at ₹684.95, while our model-based Fair Value estimate is ₹149.56, 78% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ₹152.05 per share, and 0 of the 24 models we run sit above the ₹684.95 price.
Bear case: the Asset-Based group reads lowest at ₹34.89, and 24 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹112.16 (bear) to ₹186.94 (bull), the price of ₹684.95 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Fairchem Organics Limited reported revenue of ₹4.6B in FY2026 versus ₹6.4B in FY2022, a compound −8.0%/yr. Reported net income was ₹55.4M in FY2026, compounding −46.6%/yr from FY2022.
Key figures
Market cap ₹8.6B (≈ $92.1M) Micro · P/E ratio 37.0 · P/S ratio 1.54 · EPS (TTM) ₹18.49 · Dividend yield 0.1% · Net margin 4.3% · Return on equity 8.3% · Return on assets (EBIT) 19.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (medium confidence).
What moves the price
The share trades about 19% below its 52-week high and 58% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −42% fair-value upside, at −78%, FAIRCHEMOR screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (₹34.89 to ₹626.42). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear₹112.16Fair Value ₹149.56Bull₹186.94
Price ₹684.95 · Downside -78.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹10.83 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF₹136.64₹167.80₹216.7280
Growth DCF₹139.41₹165.94₹205.1578
Owner Earnings₹66.64₹81.73₹105.4176
All 24 models by family
DCF Models
FCF DCF₹136.64₹167.80₹216.7280
Owner Earnings₹66.64₹81.73₹105.4176
5Y Revenue Exit₹104.37₹134.11₹177.0272
5Y EBITDA Exit₹124.19₹168.34₹226.8274
5Y P/E Exit₹93.37₹115.12₹141.6470
10Y Revenue Exit₹118.89₹139.11₹159.3066
10Y EBITDA Exit₹129.91₹156.13₹182.7768
10Y P/E Exit₹114.81₹129.67₹142.6263
Earnings-Based
Graham-Dodd₹29.91₹36.56₹41.1365
EPV₹46.56₹51.50₹55.4374
Dividend Discount
Gordon GGM₹49.40₹52.47₹56.9667
DDM Multi-Stage₹49.40₹56.06₹64.2265
Multiples
P/E Multiple₹56.08₹74.78₹93.4763
P/S Multiple₹56.08₹74.78₹93.4758
P/B Multiple₹469.82₹626.42₹783.0355
EV/EBIT₹22.77₹52.20₹81.6462
EV/EBITDA₹63.17₹106.08₹148.9865
EV/Revenue₹10.99₹43.79₹76.5949
Asset-Based
NCAV (Graham)₹23.03₹34.89₹43.6254
Growth DCF
Growth DCF₹139.41₹165.94₹205.1578
Rev-Margin DCF₹104.37₹138.15₹181.2471
Economic Profit
Residual Income₹116.69₹122.01₹129.6574
ROIC Compounder₹46.56₹51.50₹55.4370
Growth Earnings
Growth-Adj P/E₹39.95₹57.08₹74.2065
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−14.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.0%
Start year 2021 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−32.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−33.0%
Dividend (yield on the price)0.1%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 2%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+34.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +28.7% a year for the price.
Compare Fairchem Organics Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 754 stocks
Beats the industry median on 3/13 measures
Overall it trails its industry peers.
Valuation
Quality Score55 · Above median
Fair Value upside−78.2% · Bottom 25%
Profitability
Return on equity (12 months)8.3% · Above median
Return on assets1.4% · Below median
Net margin (12 months)4.3% · Below median
Operating margin (12 months)8.8% · Below median
Growth and dividend
Revenue growth (quarter YoY)49.7% · Top 25%
Dividend yield (12 months)0.1% · Bottom 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)37.0× · Pricier than median
P/B3.28× · Priciest 25%
P/S (12 months)1.54× · Pricier than median
Price / free cash flow (fiscal year)37.7× · Pricier than median
EV/EBITDA18.2× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 4
FUTURE (revenue growth)100· sector 66
PAST (return on equity)33· sector 26
HEALTH (low debt)100· sector 95
DIVIDEND (yield)3· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Fairchem Organics Limited (FAIRCHEMOR) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of ₹149.56 versus a price of ₹684.95, about 78% lower (overvalued).
What is the fair value of FAIRCHEMOR?
Our model-based fair value for Fairchem Organics Limited is ₹149.56 (as of Nov 12, 2026), built from audited fundamentals. The current price: ₹684.95.
What is the quality score of FAIRCHEMOR?
Fairchem Organics Limited has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Fairchem Organics Limited (FAIRCHEMOR)?
Our model-based price target is the fair value of ₹149.56 (as of Nov 12, 2026) from 24 valuation models. Cautious scenario ₹112.16, optimistic scenario ₹186.94. It is a calculation from audited fundamentals, not an analyst target.
What is the Fairchem Organics Limited stock forecast for 2026?
Our models put fair value at ₹149.56, about 78% lower versus a price of ₹684.95 (overvalued). Cautious scenario ₹112.16, optimistic scenario ₹186.94. The calculation is refreshed regularly with new filings.
What is the revenue of Fairchem Organics Limited (FAIRCHEMOR)?
Fairchem Organics Limited reported trailing-twelve-month revenue of about ₹5.6B (latest available figure, as of Nov 12, 2026).
Does Fairchem Organics Limited pay a dividend?
Fairchem Organics Limited currently shows a dividend yield of 0.15% relative to its recent price (as of Nov 12, 2026).
How much is the dividend of Fairchem Organics Limited (FAIRCHEMOR) and when is the ex-dividend date?
Fairchem Organics Limited pays a dividend of ₹1.00 per share a year, a dividend yield of 0.1%. The last ex-dividend date was Jul 20, 2026. A dividend has been paid every year since at least 2021. The payout ratio is 5.4% of earnings. Free cash flow covers the dividend 18.19 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Fairchem Organics Limited (FAIRCHEMOR)?
For today's price to be fair in a discounted-cash-flow model, Fairchem Organics Limited would have to grow free cash flow by +34.0 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.0 % per year. As of Nov 12, 2026.
What discount rate (WACC) does the fair value of FAIRCHEMOR use?
Our models discount Fairchem Organics Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.46, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Fairchem Organics Limited that is +34.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has Fairchem Organics Limited (FAIRCHEMOR) delivered so far?
Over the past 5 years revenue at Fairchem Organics Limited grew +3.0 % a year. The price currently implies free-cash-flow growth of +34.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Fairchem Organics Limited (FAIRCHEMOR) growing?
The median revenue growth in the sector is +8.7 % a year. That is the yardstick for the growth priced into Fairchem Organics Limited (+34.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Fairchem Organics Limited (FAIRCHEMOR)?
The free-cash-flow yield on the price is 2.66 %: that much free cash flow Fairchem Organics Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Fairchem Organics Limited (FAIRCHEMOR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Fairchem Organics Limited it is ₹149.56 per share (as of Nov 12, 2026), against a price of ₹684.95. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Fairchem Organics Limited stock overvalued or undervalued in 2026?
As of Nov 12, 2026, FAIRCHEMOR trades above its calculated fair value: price ₹684.95, fair value ₹149.56, a gap of about −78% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FAIRCHEMOR?
No. The price is what the market pays today (₹684.95); the fair value is what the company's own numbers justify (₹149.56). For Fairchem Organics Limited the two are ₹535.39 per share apart. That gap is exactly why we show both numbers side by side.
How much is Fairchem Organics Limited worth?
The market values Fairchem Organics Limited at about ₹8.6B (market capitalisation, as of Nov 12, 2026). Per share that is ₹684.95; our models calculate a fair value of ₹149.56 per share.
What do the bullish and bearish scenarios say about FAIRCHEMOR?
Our models span a range for Fairchem Organics Limited: cautious scenario ₹112.16, base ₹149.56, optimistic ₹186.94 per share (as of Nov 12, 2026, price ₹684.95). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of FAIRCHEMOR?
Fairchem Organics Limited trades at a price-to-earnings ratio of 37.0 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹149.56 is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2021 to 2026), reported earnings: 33.5. Other multiples: P/B 3.3, P/S 1.5, EV/EBITDA 18.2.
How solid is the balance sheet of Fairchem Organics Limited (FAIRCHEMOR)?
Balance-sheet figures for Fairchem Organics Limited (as of Nov 12, 2026): return on equity 8.3%. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is FAIRCHEMOR from its 52-week high?
Fairchem Organics Limited trades at ₹684.95, about 19% below its 52-week high of ₹846.80 and 58% above the low of ₹433.00 (as of Nov 12, 2026). Distance from the high says nothing about value: that is what the fair value of ₹149.56 is for.
Which stocks are comparable to Fairchem Organics Limited?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Fairchem Organics Limited stock attractive at the current price?
The data as of Nov 12, 2026: price ₹684.95, calculated fair value ₹149.56 (−78%), Quality Score 55/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FAIRCHEMOR calculated?
We run Fairchem Organics Limited through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹149.56 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0% above its aggregate fair value. Fairchem Organics Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Fairchem Organics Limited (FAIRCHEMOR)?
The closing price on Nov 12, 2026 was ₹684.95. Our model-based fair value is ₹149.56, about 78% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Fairchem Organics Limited right now?
The price sits above even our optimistic bull case (₹186.94). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Fairchem Organics Limited
How large is the market capitalisation of Fairchem Organics Limited (FAIRCHEMOR)?
The market capitalisation of Fairchem Organics Limited is ₹8.6B (≈ $92.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Fairchem Organics Limited (FAIRCHEMOR)?
The price-to-sales ratio of Fairchem Organics Limited is 1.54 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Fairchem Organics Limited (FAIRCHEMOR)?
Earnings per share at Fairchem Organics Limited are ₹18.49 (price ÷ EPS = P/E 37.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Fairchem Organics Limited (FAIRCHEMOR)?
The dividend yield of Fairchem Organics Limited is 0.1% (payout 5.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Fairchem Organics Limited (FAIRCHEMOR)?
The net margin of Fairchem Organics Limited is 4.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Fairchem Organics Limited (FAIRCHEMOR)?
The return on equity (ROE) of Fairchem Organics Limited is 8.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Fairchem Organics Limited (FAIRCHEMOR)?
On an EBIT basis the return on assets of Fairchem Organics Limited is 19.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Fairchem Organics Limited (FAIRCHEMOR)?
The operating margin of Fairchem Organics Limited is 8.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Fairchem Organics Limited (FAIRCHEMOR)?
Revenue at Fairchem Organics Limited is growing +49.7% versus a year earlier (3y avg −10.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Fairchem Organics Limited (FAIRCHEMOR)?
Earnings per share at Fairchem Organics Limited are growing +12.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Fairchem Organics Limited (FAIRCHEMOR) carry?
The net debt of Fairchem Organics Limited is ₹826M (fiscal year 2026, ≈ 3.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Fairchem Organics Limited in the live analysis
One click puts Fairchem Organics Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 12, 2026